造血干细胞移植后M2BPGi升高与非复发死亡率风险相关
本研究探讨半乳糖凝集素-3、Mac-2结合蛋白及M2BP糖异构体(M2BPGi)对造血干细胞移植后慢性移植物抗宿主病(cGVHD)及非复发死亡率(NRM)的预测价值。在发现队列(n=55)和验证队列1(n=55)中,仅第+180天M2BPGi与较高NRM显著相关,并在验证队列2(n=50)中确认。M2BPGi与肝脏cGVHD相关,是多变量分析中NRM的独立危险因素。
要点
- 第+180天M2BPGi升高与移植后晚期NRM风险增加显著相关。
- M2BPGi与肝脏cGVHD显著相关,与其他器官cGVHD无关。
- M2BPGi是多变量分析中NRM的独立危险因素。
核心结论
- M2BPGi可能是HSCT后晚期NRM的有前景预测标志物,并与肝脏受累相关。
研究设计与样本
- 纳入首次异基因HSCT后存活>180天且无复发的患者,使用发现队列(n=55)和验证队列1(n=55)评估3种标志物对NRM的预测价值,并在验证队列2(n=50)中确认。
主要发现
- 在发现队列中,第+180天M2BPGi高于ROC曲线确定的阈值与5年NRM较高显著相关(15.0% vs 0.0%,P = .001)。
- 在验证队列1中,M2BPGi升高与5年NRM较高显著相关(34.0% vs 8.4%,P = .014)。
- M2BPGi在健康个体或接受自体HSCT的患者中未升高。
- 在整个队列(N=110)中,M2BPGi与肝脏cGVHD显著相关,与其他器官受累无关。
- 多变量分析中,M2BPGi是NRM的独立危险因素;尸检免疫荧光显示WFA+-M2BP阳性巨噬细胞仅见于伴cGVHD的肝脏切片。
临床怎么用
- HSCT后第+180天可检测M2BPGi以辅助识别晚期NRM高风险患者,尤其关注肝脏cGVHD患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Macrophages play a crucial role in the pathogenesis of chronic graft-versus-host disease (cGVHD). We hypothesized that galectin-3, Mac-2 binding protein (M2BP), or Wisteria floribunda agglutinin (WFA)+-M2BP, called M2BP glycan isomer (M2BPGi), might contribute to macrophage activation, and fibrosis would be associated with cGVHD and nonrelapse mortality (NRM) in hematopoietic stem cell transplant (HSCT) recipients. Patients who underwent their first allogeneic HSCT and survived for >180 days without relapse were included. The predictive potential of the 3 markers for NRM was assessed using the discovery cohort (n = 55) and validation cohort 1 (n = 55). When we used the threshold determined by a receiver operating characteristics curve analysis in the discovery cohort, only M2BPGi at day +180 was significantly associated with a higher NRM in the discovery cohort (15.0% vs 0.0% at 5 years, P = .001) and in validation cohort 1 (34.0% vs 8.4% at 5 years, P = .014). This result was confirmed in validation cohort 2 (n = 50). M2BPGi was not increased in healthy individuals or in patients who received autologous HSCT. In the entire cohort (N = 110), M2BPGi was significantly related to liver cGVHD but not to other organ involvement. In multivariate analyses, M2BPGi was an independent risk factor for NRM. In immunofluorescence staining of autopsy cases, WFA+-M2BP-positive macrophages were found only in the liver sections with cGVHD. In conclusion, M2BPGi could be a promising predictor of late NRM after HSCT and was associated with liver involvement.
引用
- Akahoshi Y, Nakasone H, Kawamura K, et al. Increased Mac-2 binding protein glycan isomer in patients at risk for late nonrelapse mortality after HSCT. Blood Adv. 2019. PMID: 31698460. doi:10.1182/bloodadvances.2019000629
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。